Enteric solid oral dosage form of bisphosphonate containing a chelating agent

Details for Australian Patent Application No. 2008202652 (hide)

Owner The Procter & Gamble Company

Inventors Burgio Jr., David Ernest; Dansereau, Richard John

Agent Pizzeys

Pub. Number AU-B-2008202652

Parent 2005247299

Filing date 16 June 2008

Wipo publication date 10 July 2008

Acceptance publication date 11 February 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

Event Publications

3 July 2008 Complete Application Filed

10 July 2008 Application Open to Public Inspection

  Published as AU-B-2008202652

11 February 2010 Application Accepted

  Published as AU-B-2008202652

25 February 2010 Assignment before Grant

  The Procter & Gamble Company The application has been assigned to Warner Chilcott Company, LLC

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202653-Apparatus, method, and computer program product for building virtual networks

2008202651-Hyaluronan synthase genes and expression thereof